TLR4 and diabetic kidney disease: ORI can also inhibit the inflammatory reaction of diabetes nephropathy rats, reduce the level of inflammatory cytokines, and alleviate the infiltration of inflammatory cells in renal tissue through inhibiting TLR4/p38-MAPK and TLR4/NF-κB pathways [13].